508 related articles for article (PubMed ID: 11102568)
1. delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury.
Zhang J; Haddad GG; Xia Y
Brain Res; 2000 Dec; 885(2):143-53. PubMed ID: 11102568
[TBL] [Abstract][Full Text] [Related]
2. Activation of mu- and delta-opioid receptors causes presynaptic inhibition of glutamatergic excitation in neocortical neurons.
Ostermeier AM; Schlösser B; Schwender D; Sutor B
Anesthesiology; 2000 Oct; 93(4):1053-63. PubMed ID: 11020761
[TBL] [Abstract][Full Text] [Related]
3. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
Tao R; Auerbach SB
J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of opioid receptors involved in modulating circular and longitudinal muscle contraction in the rat ileum.
Gray AC; White PJ; Coupar IM
Br J Pharmacol; 2005 Mar; 144(5):687-94. PubMed ID: 15678085
[TBL] [Abstract][Full Text] [Related]
5. Feeding responses to mu-, delta- and kappa-opioid receptor agonists in the meat-type chick.
Bungo T; Kawamura K; Izumi T; Dodo K; Ueda H
Pharmacol Biochem Behav; 2004 Aug; 78(4):707-10. PubMed ID: 15301925
[TBL] [Abstract][Full Text] [Related]
6. Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response.
Spadoni F; Martella G; Martorana A; Lavaroni F; D'Angelo V; Bernardi G; Stefani A
Synapse; 2004 Mar; 51(3):194-205. PubMed ID: 14666517
[TBL] [Abstract][Full Text] [Related]
7. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
8. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
[TBL] [Abstract][Full Text] [Related]
9. Gastric effects of methylnaltrexone on mu, kappa, and delta opioid agonists induced brainstem unitary responses.
Yuan CS; Foss JF
Neuropharmacology; 1999 Mar; 38(3):425-32. PubMed ID: 10219980
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective role of delta-opioid receptors in cortical neurons.
Zhang J; Gibney GT; Zhao P; Xia Y
Am J Physiol Cell Physiol; 2002 Jun; 282(6):C1225-34. PubMed ID: 11997236
[TBL] [Abstract][Full Text] [Related]
11. Relationship between inhibitory effect of endogenous opioid via mu-receptors and muscarinic autoinhibition in acetylcholine release from myenteric plexus of guinea pig ileum.
Nishiwaki H; Saitoh N; Nishio H; Takeuchi T; Hata F
Jpn J Pharmacol; 1998 Aug; 77(4):279-86. PubMed ID: 9749928
[TBL] [Abstract][Full Text] [Related]
12. Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats.
Kakinohana M; Nakamura S; Fuchigami T; Davison KJ; Marsala M; Sugahara K
Br J Anaesth; 2006 Jan; 96(1):88-94. PubMed ID: 16317029
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of phospholipase C by the cloned mu, delta and kappa opioid receptors via chimeric G alpha(q) mutants.
Joshi S; Lee JW; Wong YH
Eur J Neurosci; 1999 Feb; 11(2):383-8. PubMed ID: 10051738
[TBL] [Abstract][Full Text] [Related]
14. Opioidergic modulation of voltage-activated K+ currents in magnocellular neurons of the supraoptic nucleus in rat.
Müller W; Hallermann S; Swandulla D
J Neurophysiol; 1999 Apr; 81(4):1617-25. PubMed ID: 10200198
[TBL] [Abstract][Full Text] [Related]
15. Rapid hypoxia preconditioning protects cortical neurons from glutamate toxicity through delta-opioid receptor.
Zhang J; Qian H; Zhao P; Hong SS; Xia Y
Stroke; 2006 Apr; 37(4):1094-9. PubMed ID: 16514101
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective role of delta-opioid receptors against mitochondrial respiratory chain injury.
Zhu M; Li MW; Tian XS; Ou XM; Zhu CQ; Guo JC
Brain Res; 2009 Feb; 1252():183-91. PubMed ID: 19056363
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment.
Yang L; Islam MR; Karamyan VT; Abbruscato TJ
Brain Res; 2015 Jun; 1609():1-11. PubMed ID: 25801116
[TBL] [Abstract][Full Text] [Related]
18. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo.
Collin E; Frechilla D; Pohl M; Bourgoin S; Le Bars D; Hamon M; Cesselin F
Brain Res; 1993 Apr; 609(1-2):211-22. PubMed ID: 8389648
[TBL] [Abstract][Full Text] [Related]
19. Altered opioid-mediated control of the spinal release of dynorphin and met-enkephalin in polyarthritic rats.
Ballet S; Mauborgne A; Hamon M; Cesselin F; Collin E
Synapse; 2000 Sep; 37(4):262-72. PubMed ID: 10891863
[TBL] [Abstract][Full Text] [Related]
20. Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates.
Belanger S; Ma W; Chabot JG; Quirion R
Neuroscience; 2002; 115(2):441-53. PubMed ID: 12421610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
